These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2573212)

  • 21. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB; Jamal SM; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
    Wright DJ; Cooke GA; Tan LB
    Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of carvedilol on ventricular arrhythmias.
    Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of angina pectoris].
    Scrutinio D; Chiddo A; Mastrangelo D; Lagioia R; Rizzon P
    Cardiologia; 1985 Jan; 30 Suppl 1():1-93. PubMed ID: 2864136
    [No Abstract]   [Full Text] [Related]  

  • 28. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease.
    Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M
    Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 30. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ; Hackam DG
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 32. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree?
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546
    [No Abstract]   [Full Text] [Related]  

  • 33. Carvedilol: therapeutic application and practice guidelines.
    Bleske BE; Gilbert EM; Munger MA
    Pharmacotherapy; 1998; 18(4):729-37. PubMed ID: 9692647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
    Horenstein MS; Ross RD; Singh TP; Epstein ML
    Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
    Szwed H; Hradec J; Préda I
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat.
    Feuerstein GZ; Fisher M; Nunnart J; Ruffolo RR
    Pharmacology; 1997 Jan; 54(1):24-32. PubMed ID: 9065958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol--A new nonselective beta blocker.
    Forrest E; Stanley A; Hayes P
    Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.